Home > Journals > Minerva Medica > Past Issues > Minerva Medica 2017 August;108(4) > Minerva Medica 2017 August;108(4):357-69

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

MINERVA MEDICA

A Journal on Internal Medicine


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,878


eTOC

 

REVIEW  


Minerva Medica 2017 August;108(4):357-69

DOI: 10.23736/S0026-4806.17.05058-3

Copyright © 2017 EDIZIONI MINERVA MEDICA

language: English

The current management of renal cell carcinoma

Teele KUUSK, Nikolaos GRIVAS, Roderick de BRUIJN, Axel BEX

Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands


PDF  


INTRODUCTION: Although the broad use of ultrasound and computed tomography (CT) has led to an early diagnosis of the disease, renal cell carcinoma (RCC) remains one of the most lethal urological cancers. The present review is based on the latest data published on RCC management.
EVIDENCE ACQUISITION: A literature search was carried out searching recent publications from PubMed, MEDLINE, Embase up to December 2016 as well as European Association of Urology (EAU) and European Society of Medical Oncology (ESMO) guidelines.
EVIDENCE SYNTHESIS: A narrative synthesis based on recent publications was undertaken. Current evidence regarding treatment strategies and guidelines is based on prospective randomized controlled trials and retrospective studies although the level of evidence for surgical management is generally lower than for systemic therapy.
CONCLUSIONS: This narrative review depicts a summary of the evidence base for treatment of RCC. Management of RCC is a rapidly evolving and changing field. As a consequence guidelines need regular updating and patients may benefit from centralization of care and multidisciplinary approach.


KEY WORDS: Kidney neoplasms - Carcinoma, renal cell - Therapy

top of page

Publication History

Issue published online: June 28, 2017
Article first published online: February 7, 2017

Cite this article as

Kuusk T, Grivas N, de Bruijn R, Bex A. The current management of renal cell carcinoma. Minerva Med 2017;108:357-69. DOI: 10.23736/S0026-4806.17.05058-3

Corresponding author e-mail

a.bex@nki.nl